Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis
Harenberg J. 1, Marx S. 1, 2, Diener H.-C. 3, Lip G. Y. H. 4, Marder V. J. 5, Wehling M. 1, Weiss C. 2
International Angiology 2012 August;31(4)330-9
Код: Выделить всё
http://www.minervamedica.it/en/journals/international-angiology/article.php?cod=R34Y2012N04A0330